Cargando…

Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome

BACKGROUND: Inflammation and immune activation have repeatedly been suggested as pathogentic factors in irritable bowel syndrome (IBS). The driving force for immune activation in IBS remains unknown. The aim of our study was to find out if the obligate intracellular pathogen Chlamydia could be invol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dlugosz, Aldona, Törnblom, Hans, Mohammadian, Ghazaleh, Morgan, Gareth, Veress, Béla, Edvinsson, Benjamin, Sandström, Gunnar, Lindberg, Greger
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834606/ https://www.ncbi.nlm.nih.gov/pubmed/20158890 http://dx.doi.org/10.1186/1471-230X-10-19

Ejemplares similares

Human enteroendocrine cell responses to infection with Chlamydia trachomatis: a microarray study
por: Dlugosz, Aldona, et al.
Publicado: (2014)

No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls
por: Dlugosz, Aldona, et al.
Publicado: (2015)

Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome
por: Dlugosz, Aldona, et al.
Publicado: (2017)

Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2016)

Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance
por: Mazzawi, Tarek, et al.
Publicado: (2017)

Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

Bowel obstruction due to Chlamydia trachomatis: a case report and review of literature
por: Shibasaki, Yuta, et al.
Publicado: (2021)

Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity
por: Castro Tejera, Valeria, et al.
Publicado: (2022)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Loose ends in the differential diagnosis of IBS-like symptoms
por: Lindberg, Greger, et al.
Publicado: (2023)

Increased Prevalence of Rare Sucrase-isomaltase (SI) Pathogenic Variants in Irritable Bowel Syndrome Patients
por: Garcia-Etxebarria, Koldo, et al.
Publicado: (2018)

Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
por: Lövdahl, Jenny, et al.
Publicado: (2022)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
por: Melchior, Chloé, et al.
Publicado: (2022)

Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2018)

Chlamydia trachomatis Genital Infections
por: O’Connell, Catherine M., et al.
Publicado: (2016)

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome
por: Ahluwalia, Bani, et al.
Publicado: (2021)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
por: Melchior, Chloé, et al.
Publicado: (2022)

Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome
por: Josefsson, Axel, et al.
Publicado: (2022)

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2021)

Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms
por: Midenfjord, Irina, et al.
Publicado: (2020)

Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome
por: Tap, Julien, et al.
Publicado: (2021)

Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome
por: Nybacka, Sanna, et al.
Publicado: (2020)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Defining the irritable bowel
por: Chuah, Kee Huat, et al.
Publicado: (2022)

Chlamydia Trachomatis Tonsillopharyngitis
por: Öztürk, Özmen, et al.
Publicado: (2012)

Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome
por: Colomier, Esther, et al.
Publicado: (2022)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome
por: Major, Giles, et al.
Publicado: (2014)

Is irritable bowel syndrome a dysbiotic bowel syndrome?
por: Benno, Peter, et al.
Publicado: (2015)

Volatomics in inflammatory bowel disease and irritable bowel syndrome
por: Van Malderen, Kathleen, et al.
Publicado: (2020)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

miR-16 and miR-103 impact 5-HT(4) receptor signalling and correlate with symptom profile in irritable bowel syndrome
por: Wohlfarth, Carolin, et al.
Publicado: (2017)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Irritable Brain Caused by Irritable Bowel? A Nationwide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder
por: Liu, Chia-Jen, et al.
Publicado: (2015)

The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options
por: Nybacka, Sanna, et al.
Publicado: (2022)

Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection
por: Qi, Man-Li, et al.
Publicado: (2017)

Changes in serum and urinary metabolomic profile after a dietary intervention in patients with irritable bowel syndrome
por: Nybacka, Sanna, et al.
Publicado: (2021)

New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond
por: Sinagra, Emanuele, et al.
Publicado: (2017)

ALEXITHYMIA IN IRRITABLE BOWEL SYNDROME
por: Arun, Priti
Publicado: (1998)

Probiotics and irritable bowel syndrome
por: Korpela, Riitta, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g1eg21nr2ohmtnckduhdvo359a